Compare COCO & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COCO | QDEL |
|---|---|---|
| Founded | 2004 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Medical Specialities |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 1.7B |
| IPO Year | 2021 | N/A |
| Metric | COCO | QDEL |
|---|---|---|
| Price | $54.32 | $27.74 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 6 |
| Target Price | ★ $55.13 | $39.33 |
| AVG Volume (30 Days) | 923.0K | ★ 1.5M |
| Earning Date | 10-29-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 15.16 | N/A |
| EPS | ★ 1.15 | N/A |
| Revenue | $609,286,000.00 | ★ $2,714,400,000.00 |
| Revenue This Year | $18.22 | N/A |
| Revenue Next Year | $13.69 | $2.42 |
| P/E Ratio | $47.36 | ★ N/A |
| Revenue Growth | ★ 23.12 | N/A |
| 52 Week Low | $25.79 | $19.50 |
| 52 Week High | $55.09 | $49.45 |
| Indicator | COCO | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 74.25 | 58.70 |
| Support Level | $53.63 | $26.52 |
| Resistance Level | $55.09 | $28.37 |
| Average True Range (ATR) | 2.08 | 1.24 |
| MACD | 0.47 | 0.61 |
| Stochastic Oscillator | 93.61 | 91.19 |
The Vita Coco Co Inc is a plant-based functional hydration platform. Its products include Vita Coco Coconut Water, Private Label including coconut water and oil, and Other including Runa, Ever & Ever, and PWR LIFT product offerings, Vita Coco product extensions beyond coconut water, such as Vita Coco Sparkling, coconut milk products, and others. The company has two segments: The Americas segment which comprises of operations in the U.S. and Canada; and The International segment that comprises of operations in Europe, the Middle East, Africa and the Asia Pacific regions. The Americas segment derives maximum revenue. Geographical presence of the company is in United States, United Kingdom and All other countries.
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.